Smartleaf Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Smartleaf Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.35K	Sell	359 -189	-34%	-$3.66K	﹤0.01%	2464
2025 Q4	$11.8K	Buy	548 +479	+694%	+$10.1K	﹤0.01%	2320
2025 Q3	$1.3K	Sell	69 -63	-48%	-$1.12K	﹤0.01%	2699
2025 Q2	$2.26K	Sell	132 -179	-58%	-$7.64K	﹤0.01%	2304
2025 Q1	$21.9K	Sell	311 -131	-30%	-$13.8K	﹤0.01%	1566
2024 Q4	$53.6K	Buy	442 +216	+96%	+$26.5K	0.01%	1151
2024 Q3	$28.1K	Buy	226 +114	+102%	+$15.8K	﹤0.01%	1154
2024 Q2	$17.7K	Buy	112 +57	+104%	+$7.32K	﹤0.01%	1089
2024 Q1	$7.16K	Hold	55	–	–	﹤0.01%	1101
2023 Q4	$5.38K	Buy	+55	New	+$5.28K	﹤0.01%	853

Other funds holding SRPT

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

First Trust Advisors

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return